Lead Product(s) : Tranilast
Therapeutic Area : Rheumatology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 22, 2010
Lead Product(s) : Tranilast
Therapeutic Area : Rheumatology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tranilast
Therapeutic Area : Rheumatology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 21, 2010
Lead Product(s) : Tranilast
Therapeutic Area : Rheumatology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
